Repare Therapeutics Inc.

10/08/2021 | Press release | Distributed by Public on 10/08/2021 13:18

Repare Therapeutics Presents Preliminary Phase 1 Monotherapy Clinical Data from the Ongoing First-in-Human Phase 1/2 TRESR Study of RP-3500 in Solid Tumors at AACR-NCI-EORTC[...]